ctrl K

BioAge Labs Inc. (BIOA)

NASDAQ: BIOA · Real-Time Price · USD

4.13

-0.07 (-1.67%)

At close: May 01, 2025, 3:59 PM

4.33

4.72%

After-hours: May 01, 2025, 06:07 PM EDT

BioAge Labs Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-25.36M	-24.75M	-15.27M	-12.81M	-13.6M	-9.89M	-13.41M	-11.51M
Interest Income	4.09M	2.04M	2.2M	1.3M	379K	499K	318K	1.24M
Pretax Income	-21.13M	-23.41M	-13.58M	-12.99M	-20.96M	-14.63M	-17.19M	-11.08M
Net Income	-21.13M	-23.41M	-13.58M	-12.99M	-20.96M	-14.63M	-17.19M	-11.08M
Selling & General & Admin	6.14M	4.73M	4.8M	3.49M	3.51M	3.35M	4.18M	3.47M
Research & Development	19.23M	20.02M	10.47M	9.32M	10.08M	6.53M	9.23M	8.04M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	25.36M	24.75M	15.27M	12.81M	13.6M	9.89M	13.41M	11.51M
Interest Expense	319K	388K	443K	1.22M	2.56M	2.4M	2.04M	793K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	25.36M	24.75M	15.27M	12.81M	13.6M	9.89M	13.41M	11.51M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	35.85M	3.49M	7.55M	7.47M	7.47M	7.46M	7.46M	7.46M
Shares Outstanding (Diluted)	35.85M	3.49M	7.55M	7.47M	7.47M	7.46M	7.46M	7.46M
EPS (Basic)	-1.97	-6.7	-1.8	-1.74	-2.81	-1.96	-2.3	-1.48
EPS (Diluted)	-1.97	-6.7	-1.8	-1.74	-2.81	-1.96	-2.3	-1.48
EBITDA	-20.76M	-22.98M	-13.09M	-11.74M	-18.36M	-12.17M	-15.11M	-10.26M
EBIT	-20.81M	-23.02M	-13.14M	-11.78M	-18.4M	-12.22M	-15.15M	-10.29M
Depreciation & Amortization	47K	38K	49K	33K	41K	48K	40K	33K